← Leaderboards
Mitchell L Leibowitz
Dana-Farber Cancer Inst
$221,404
Attributed
$221,404
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $78K · FY2023–25$100K$75K$50K$25K$0
'23
'24
'25
Funding mix
By agency
NIH$221,404 · 1
By mechanism
F32$221,404 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- David S Pellman$18,057,380
- Rameen Beroukhim$9,639,646
- Heng Li$6,929,908
- Benjamin Levine Ebert$26,802,844
- Jeffrey Wade Harper$36,219,392
Others in their field
Other Rising Stars on “Apoptosis”
- Hill Georgette · Integrated Laboratory Systems, Llc$8,700,000
- Charles Dimmler III · Ceramedix Holding, Llc$4,223,612
- Stuart Marcus · Sonalasense Inc$3,968,035
- Jens Eickhoff · University Of Wisconsin-Madison$3,606,160
- Salwa A Elgebaly · Nour Heart, Inc.$3,582,845
- Galina Vid · Ceramedix Holding, Llc$3,007,043
Research focus
ApoptosisApoptoticBiological MarkersCancer CellCancer Cell LineCancer GenomeCancer GenomicsCancer PatientCancer TherapyCancer TypeCareerCell CycleCell DeathCell Death InductionCell KillingCell LineCellsCell SurvivalCell TypeCessation Of LifeChemotherapyChromosomal DuplicationChromosome LossAffect
Grant awards (3)
Targeting the cancer neo-genome for destruction with CRISPR-Cas enzymes$78,040
F32 · FY2025 · CA · contact PI
Targeting the cancer neo-genome for destruction with CRISPR-Cas enzymes$74,284
F32 · FY2024 · CA · contact PI
Targeting the cancer neo-genome for destruction with CRISPR-Cas enzymes$69,080
F32 · FY2023 · CA · contact PI